gefitinib has been researched along with fosbretabulin in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (fosbretabulin) | Trials (fosbretabulin) | Recent Studies (post-2010) (fosbretabulin) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 497 | 0 | 320 |
| Protein | Taxonomy | gefitinib (IC50) | fosbretabulin (IC50) |
|---|---|---|---|
| Tubulin polymerization-promoting protein | Homo sapiens (human) | 1.016 | |
| Tubulin alpha-1A chain | Sus scrofa (pig) | 1.82 | |
| Tubulin beta chain | Sus scrofa (pig) | 1.9428 | |
| Tubulin beta-4A chain | Homo sapiens (human) | 1.663 | |
| Tubulin beta chain | Homo sapiens (human) | 1.663 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 0.009 | |
| Tubulin alpha-3C chain | Homo sapiens (human) | 1.663 | |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 1.08 | |
| Delta-type opioid receptor | Mus musculus (house mouse) | 1.005 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.81 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 1.2 | |
| Tubulin alpha-1B chain | Homo sapiens (human) | 1.663 | |
| Tubulin alpha-4A chain | Homo sapiens (human) | 1.663 | |
| Tubulin beta-4B chain | Homo sapiens (human) | 1.663 | |
| Vesicular acetylcholine transporter | Tetronarce californica (Pacific electric ray) | 1.8 | |
| Tubulin beta-3 chain | Homo sapiens (human) | 1.5801 | |
| Tubulin beta-2A chain | Homo sapiens (human) | 1.663 | |
| Beta-tubulin | Leishmania donovani | 1.95 | |
| Tubulin beta-8 chain | Homo sapiens (human) | 1.663 | |
| Tubulin beta-2B chain | Bos taurus (cattle) | 1.4484 | |
| Tubulin alpha-3E chain | Homo sapiens (human) | 1.663 | |
| Tubulin alpha-1A chain | Homo sapiens (human) | 1.663 | |
| Similar to alpha-tubulin isoform 1 | Bos taurus (cattle) | 1.4928 | |
| Similar to alpha-tubulin isoform 1 | Bos taurus (cattle) | 1.4037 | |
| Tubulin alpha-1C chain | Homo sapiens (human) | 1.663 | |
| Tubulin beta-6 chain | Homo sapiens (human) | 1.663 | |
| Tubulin beta-2B chain | Homo sapiens (human) | 1.663 | |
| Tubulin beta-1 chain | Homo sapiens (human) | 1.6366 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; He, L; Liu, Y; Ma, L; Nie, C; Pu, Y; Shao, M; Wang, F; Wu, W; Wu, Y; Yang, Z; Yu, K | 1 |
1 other study(ies) available for gefitinib and fosbretabulin
| Article | Year |
|---|---|
Synthesis and biological evaluation of diarylthiazole derivatives as antimitotic and antivascular agents with potent antitumor activity.
Topics: Angiogenesis Inhibitors; Animals; Antimitotic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Cell Line, Tumor; Cell Movement; Colchicine; Colonic Neoplasms; Drug Resistance, Neoplasm; Female; G2 Phase Cell Cycle Checkpoints; Gene Expression; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Inbred BALB C; Protein Binding; Stilbenes; Structure-Activity Relationship; Thiazoles; Tubulin Modulators; Xenograft Model Antitumor Assays | 2015 |